Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
FTC Files for Injunction as IML Shuts Down
Agency worries MLM defendants are dissipating assets.
Meet the Law Firm Driving a Surge in ‘Made in America’ Advertising Suits
Patrick Coffee, The Wall Street Journal
MaxAI
Web extension may be better at maxing out your credit card than the full capabilities of AI.
Workado Settles FTC Complaint Challenging AI Detection Claims
FTC alleged company vastly overstated the accuracy of its AI Content Detector tool.
Apple Intelligence Lawsuits Mounting
Apple iPhone 16 users are asking Siri, where are the AI features that were touted in ads?